Nuveen Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-325,552
| Closed | -$6.04M | – | 3384 |
|
|
2023
Q3 | $6.04M | Sell |
325,552
-107,194
| -25% | -$1.99M | ﹤0.01% | 1768 |
|
|
2023
Q2 | $4.79M | Sell |
432,746
-382,702
| -47% | -$4.23M | ﹤0.01% | 1936 |
|
|
2023
Q1 | $11M | Buy |
815,448
+17,538
| +2% | +$236K | ﹤0.01% | 1424 |
|
|
2022
Q4 | $9.87M | Buy |
797,910
+385,884
| +94% | +$4.77M | ﹤0.01% | 1497 |
|
|
2022
Q3 | $5.75M | Buy |
412,026
+94,515
| +30% | +$1.32M | ﹤0.01% | 1822 |
|
|
2022
Q2 | $4.39M | Buy |
317,511
+194,584
| +158% | +$2.69M | ﹤0.01% | 2032 |
|
|
2022
Q1 | $2.02M | Buy |
122,927
+42,851
| +54% | +$705K | ﹤0.01% | 2500 |
|
|
2021
Q4 | $1.1M | Sell |
80,076
-7,916
| -9% | -$109K | ﹤0.01% | 2828 |
|
|
2021
Q3 | $1.4M | Sell |
87,992
-5,933
| -6% | -$94.5K | ﹤0.01% | 2837 |
|
|
2021
Q2 | $1.88M | Sell |
93,925
-2,884
| -3% | -$57.6K | ﹤0.01% | 2747 |
|
|
2021
Q1 | $2.23M | Sell |
96,809
-583
| -0.6% | -$13.5K | ﹤0.01% | 2566 |
|
|
2020
Q4 | $2.41M | Sell |
97,392
-124,393
| -56% | -$3.07M | ﹤0.01% | 2415 |
|
|
2020
Q3 | $9.2M | Buy |
221,785
+117,740
| +113% | +$4.88M | ﹤0.01% | 1574 |
|
|
2020
Q2 | $4.99M | Sell |
104,045
-938
| -0.9% | -$44.9K | ﹤0.01% | 1900 |
|
|
2020
Q1 | $6.61M | Sell |
104,983
-7,502
| -7% | -$472K | ﹤0.01% | 1546 |
|
|
2019
Q4 | $13.9M | Sell |
112,485
-1,542
| -1% | -$191K | 0.01% | 1385 |
|
|
2019
Q3 | $7.57M | Sell |
114,027
-6,864
| -6% | -$456K | ﹤0.01% | 1733 |
|
|
2019
Q2 | $9.62M | Buy |
120,891
+113,549
| +1,547% | +$9.03M | ﹤0.01% | 1637 |
|
|
2019
Q1 | $821K | Buy |
+7,342
| New | +$821K | ﹤0.01% | 770 |
|
|
2014
Q2 | – | Sell |
-5,151
| Closed | -$1.7M | – | 1597 |
|
|
2014
Q1 | $1.7M | Sell |
5,151
-1,053
| -17% | -$347K | 0.01% | 838 |
|
|
2013
Q4 | $424K | Buy |
+6,204
| New | +$424K | ﹤0.01% | 1280 |
|